NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 58.19

+0.3%

1:48 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Arthur Radley	11/2/2010 9:34:46 AM
	of 507

UPDATE 1-Nektar to supply polymer to Amgen, to get $50 mln 8:01 am ET 11/02/2010 - Reuters * Nektar to get $50 mln * Says to manufacture and supply its polymer materials * Says Amgen has no minimum purchase commitments Nov 2 (Reuters) - Nektar Therapeutics <NKTR.O> said it has entered into a non-exclusive agreement to manufacture and supply proprietary polymer material to biotech firm Amgen Inc <AMGN.O>. As per the agreement signed last Friday, Nektar will receive $50 million from Amgen for the supply of certain quantities of polymer material, used in many applications from industrial manufacturing to medicine. Nektar said in case it fails to supply the required materials, Amgen will have the right to access the facility for the purpose of manufacturing the polymer material solely. Amgen has no minimum purchase commitments and Nektar is entitled to receive additional payments if Amgen orders more than specified quantities. Nektar's shares, which have gained about 50 percent since it reported promising results of its experimental ovarian cancer drug in January, closed at $14.63 Monday on Nasdaq. (Reporting by Krishnkali Sengupta in Bangalore;Editing by Prem Udayabhanu)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next